Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 23)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A ZOLL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ZOLL: the economy's impact on ZOLL's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: AHII , CMN , HOLX , MASI , OFIX , RMD , WMGI , ZOLL -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ZOLL MEDICAL CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ZOLL MEDICAL -- ZOLL 1 $4 View Abstract
3-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for ZOLL Medical Corporation 41 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ZOLL MEDICAL CORP 5 $25 View Abstract
25-Jan-10 Wall Street Transcript ,The The Wall St Transcript ANALYST INTERVIEW: Blurred Lines Between Life Sciences & Diagnostics - Stephen D. Simpson - Northland Securities, Inc. 5 $50 View Abstract
Next 13

Independent Reports (Showing 1 to 10 of 23)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A ZOLL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ZOLL: the economy's impact on ZOLL's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: AHII , CMN , HOLX , MASI , OFIX , RMD , WMGI , ZOLL -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ZOLL MEDICAL CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ZOLL MEDICAL -- ZOLL 1 $4 View Abstract
3-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for ZOLL Medical Corporation 41 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ZOLL MEDICAL CORP 5 $25 View Abstract
25-Jan-10 Wall Street Transcript ,The The Wall St Transcript ANALYST INTERVIEW: Blurred Lines Between Life Sciences & Diagnostics - Stephen D. Simpson - Northland Securities, Inc. 5 $50 View Abstract
Next 13

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.